What is a recommended tapering schedule for a patient taking Ativan (lorazepam) 2 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lorazepam (Ativan) 2 mg Tapering Schedule

The recommended tapering schedule for a patient taking Ativan (lorazepam) 2 mg is to reduce the dose by 0.5 mg every 2 weeks, followed by a reduction to 0.25-0.5 mg for elderly or debilitated patients, with a maximum of 2 mg in 24 hours. 1

Initial Assessment and Planning

Before beginning the taper:

  • Assess duration of use (short-term: <1 year; long-term: ≥1 year)
  • Evaluate risk factors for difficult withdrawal (elderly status, history of seizures, concurrent medications)
  • Discuss the tapering plan with the patient, explaining potential withdrawal symptoms

Tapering Protocol for Lorazepam 2 mg

Standard Tapering Schedule

  1. Weeks 1-2: Reduce from 2 mg to 1.5 mg daily
  2. Weeks 3-4: Reduce from 1.5 mg to 1 mg daily
  3. Weeks 5-6: Reduce from 1 mg to 0.5 mg daily
  4. Weeks 7-8: Reduce from 0.5 mg to 0.25 mg daily
  5. Weeks 9-10: Discontinue completely

This follows the FDA recommendation for a gradual taper to minimize withdrawal symptoms 1. For elderly or debilitated patients, consider starting at a lower dose (1-2 mg/day) and tapering more slowly 1.

Alternative Slower Tapering Schedule (for long-term users)

For patients who have been on lorazepam for more than a year, consider a slower taper:

  1. Month 1: Reduce from 2 mg to 1.75 mg daily
  2. Month 2: Reduce from 1.75 mg to 1.5 mg daily
  3. Month 3: Reduce from 1.5 mg to 1.25 mg daily
  4. Month 4: Reduce from 1.25 mg to 1 mg daily
  5. Month 5: Reduce from 1 mg to 0.75 mg daily
  6. Month 6: Reduce from 0.75 mg to 0.5 mg daily
  7. Month 7: Reduce from 0.5 mg to 0.25 mg daily
  8. Month 8: Discontinue completely

Managing Withdrawal Symptoms

Common withdrawal symptoms include:

  • Anxiety and agitation
  • Insomnia
  • Tremors
  • Headache
  • Nausea/vomiting
  • Sweating
  • Tachycardia/palpitations

If withdrawal symptoms become severe during tapering:

  1. Pause the taper at the current dose until symptoms resolve 1
  2. Resume tapering at a slower rate (e.g., 5% reduction instead of 10%) 2
  3. Consider symptom management with non-benzodiazepine medications:
    • Hydroxyzine for anxiety and agitation
    • Trazodone for insomnia
    • Clonidine for sympathetic hyperactivity
    • Acetaminophen for pain (not exceeding 3000mg daily) 2

Special Considerations

  • Concurrent medications: If the patient is also taking opioids, prescribe the lowest effective dosage of lorazepam and monitor closely for respiratory depression 1
  • Elderly patients: Use a slower tapering schedule with 5% reductions and more frequent monitoring 2
  • History of seizures: Consider even slower tapering and consultation with neurology
  • Pregnancy: Consult appropriate expertise before tapering due to risks to both mother and fetus 2

Follow-up and Monitoring

  • Schedule regular follow-up appointments at least monthly during the tapering process
  • Monitor for withdrawal symptoms at each visit
  • Assess for the need for adjunctive treatments to manage withdrawal symptoms
  • If withdrawal symptoms become severe, pause the taper temporarily and resume at a slower rate 2

Non-Pharmacological Support

Recommend the following supportive measures during tapering:

  • Cognitive behavioral therapy
  • Regular exercise
  • Sleep hygiene practices
  • Stress management techniques
  • Support groups

By following this structured tapering schedule and providing appropriate support, most patients can successfully discontinue lorazepam while minimizing withdrawal symptoms.

References

Guideline

Baclofen Tapering Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.